« Previous
Next »
Titles
- S9 nonclinical evaluation for anticancer pharmaceuticals: questions and answers1
- Safety and performance based pathway: guidance for industry and Food and Drug Administration1
- Special protocol assessment1
- Standards development and the use of standards in regulatory submissions reviewed in the Center for Biologics Evaluation and Research1
- Sunscreen: FDA reviewed applications for additional active ingredients and determined more data needed : report to Congressional committees1